Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
Executive Summary
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
You may also be interested in...
Czechs Start Reimbursement For Telehealth Since Pandemic Plus Picture In Eastern Europe
The practice of telehealth got the impetus it had long needed during the pandemic, as experiences in Czechia and neighboring economies in eastern Europe show in a regional roundup by Kinstellar.
South Korea Roundup: Augmented Reality Device Guidelines, Digital, UDI And IVD Updates
The devices regulator has sought private sector input in updating AR/VR guidelines, but needs to do more on telemedicine integration. Mixed experiences are reported on UDI and the new IVD regulation.
Interview: Royal Philips’ Journey From Medtech Supplier To Healthtech Partner
Health care delivery has been transformed over the past decade, and so has Royal Philips, whose CEO Frans van Houten explains why both were necessary, and the extra impetus for system-wide change following the COVID-19 pandemic.